NCCN 2018-2019 Oncology Case Manager and Medical Director Program: Recent Developments in Cancer Immunotherapy

January 10, 2019

The field of cancer immunotherapy has evolved dramatically in recent years. As increasingly greater options for, and combinations of, cancer immunotherapy become available, clinicians need to stay up-to-date on the role of immunotherapy in a rapidly changing therapeutic landscape. It is important for clinicians to be aware of the available agents, understand their appropriate use, and be equipped to recognize and treat the unique toxicities associated with immunotherapy. This knowledge is also essential to ensure that clinicians can provide appropriate patient education and guidance during shared decision making.

Target Audience

This program is designed to meet the educational needs of case managers, nurses in other roles (e.g., quality management and utilization review), medical directors at managed care organizations, reinsurers, TPAs, and case management and disease management companies who interact with, counsel, and refer patients with cancer to appropriate sources of care and/or make coverage decisions. Programs may also be of interest to nurses, nurse navigators/care coordinators, and physicians who work directly with patients in clinical settings as well as clinical pharmacists in managed care organizations and other settings.

Learning Objectives

Following this activity, participants should be able to:

  • Summarize recent advances in immunotherapy for patients with cancer.
  • Educate patients and caregivers on the available immunotherapy options in oncology.
  • Discuss important considerations for selecting immunotherapy, including treatment response rates and treatment-related toxicity.
Additional information
Supporters: 

This activity is supported by educational grants from:

  • Astellas
  • AstraZeneca
  • Celgene Corporation
  • Ethicon
  • Novartis Pharmaceuticals
  • Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.
Course summary
Available credit: 
  • 1.25 ACPE contact hours
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 ANCC contact hours
  • 1.25 CCM clock hours
  • 1.25 Participation
Course opens: 
12/05/2018
Course expires: 
03/03/2019
Event starts: 
01/10/2019 - 3:30pm
Event ends: 
01/10/2019 - 4:45pm
Cost:
$0.00

Sandip P. Patel, MD
UC San Deigo Moores Cancer Center

Disclosure of Relevant Financial Relationships
All faculty and activity planners participating in NCCN continuing education activities are expected to disclose any relevant financial relationships with a commercial interest as defined by the ACCME’s, ANCC’s, and ACPE’s Standards for Commercial Support. All faculty presentations have been reviewed for adherence to the ACCME’s Criterion 7: The provider develops activities/educational interventions independent of commercial interests (SCS 1, 2, and 6) by experts on the topics. Full disclosure of faculty relationships will be made prior to the activity.

Physicians
National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

NCCN designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1.25 hours of Category 1 credit for completing this activity.

Nurses
National Comprehensive Cancer Network (NCCN) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

NCCN designates this educational activity for a maximum of 1.25 contact hours.

Case Managers
This program has been pre-approved by The Commission for Case Manager Certification to provide continuing education credit to CCM® board certified case managers. Credit approval for case managers is pending for this program.

Pharmacists

National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

NCCN designates this knowledge-based continuing education activity for 1.25 contact hours (0.125 CEUs) of continuing education credit. UAN: TBD

Available Credit

  • 1.25 ACPE contact hours
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 ANCC contact hours
  • 1.25 CCM clock hours
  • 1.25 Participation

Accreditation Period

Course opens: 
12/05/2018
Course expires: 
03/03/2019

Price

Cost:
$0.00
Please login or register to take this course.

Click the Take Course button to register for this upcoming live webinar.

This webinar will be presented live one time only on Thursday, January 10, 2019, from 3:30 - 4:45 PM Eastern Standard Time (EST) (UTC -5).  To convert the start time of this webinar for other time zones, click here.

Required Hardware/software

To complete this activity, users will need:

  • A device with an Internet connection and sound playback capability
    • One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari
    • Internet Explorer is no longer supported
  • Adobe Reader or other PDF reader software for certificate viewing/printing